NCT05562791View on ClinicalTrials.gov

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 28, 2022

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Bladder Cancer
Interventions
DRUG

[68Ga]PSMA

68Gallium PSMA-PET/CT imaging within 10 days after standard of care FDG-PET/CT.

DIAGNOSTIC_TEST

PET/CT imaging

68Gallium PSMA-PET/CT imaging within 10 days after standard of care FDG-PET/CT.

Trial Locations (1)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER